FDA proposes change to rule on off-label drug use

(By Maia Anderson for Becker’s Hospital Review)

The FDA has issued a proposed rule that clarifies when drugmakers are required to update their drug labels to reflect off-label use, STAT reported.  Continue reading article here…


Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org

Leave a Reply